Sign in
8-K

Current Report

Liminatus Pharma, Inc. Filed Acc 0001104659-26-098335

Delisting notice · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure

  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 3.03 Material modification to rights of security holders
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading tm2623497d1_8k.htm…